Vectura appoints Mark Bridgewater as chief commercial officer

9 Mar 2020

Inhalation-focused CDMO Vectura said Monday it has appointed Mark Bridgewater as chief commercial officer, a new role focused on driving business development and growth in the pharmaceutical services space.

In his new role, Bridgewater has been tasked with implementing sales processes and building out a commercial team.

Vectura appoints Mark Bridgewater as chief commercial officer
Mark Bridgewater

“He comes to the company with an impressive track record of delivering sustained growth and market success in each of his previous roles,” said Vectura CEO Will Downie. “His versatile leadership skills and growth mindset will help accelerate the transformation of the company into a true leader in the outsourcing space.”

With more than 20 years’ experience in medical device and pharmaceutical services, Bridgewater was previously VP business development and account management for Europe and Asia at Flex, a design, engineering and manufacturing organisation.

Prior to that, he worked as VP global business development, advanced delivery technologies at Catalent and has previously held roles at Wockhardt and Patheon.